Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours Β· Estimated delivery Oct 10 - Oct 15
Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis/bladder pain syndrome after intravesical platelet-rich plasma injection
At the starting dose of 2 mg per week, one vial lasts five weeks
Each course should be followed by a pause of at least four months
Medication, Management, Monitoring, Measurement Handouts Patient Safety: Toxic Human Drugs and Their Impact on Household Pets Learning Objectives After completing this application-based continuing education activity, pharmacists will be able to: DESCRIBE common pathways through which pets are exposed to toxic human medications IDENTIFY the clinical signs and symptoms of toxicity from antidepressants, ADHD medications, NSAIDs, opioids, and recreational drugs in companion animals DISCUSS veterinary management strategies and outcomes for pets exposed to toxic medications, including decontamination, symptom management, and diagnostic testing RECOGNIZE best practices to counsel pet-owning patients on safe medication storage, disposal, and early signs of pet poisoning After completing this application-based continuing education activity, pharmacy technicians will be able to: RECOGNIZE common human medications that are toxic to pets IDENTIFY signs and symptoms of drug toxicity in companion animals that may be mentioned by pet owners at the pharmacy counter LIST proper techniques for medication storage and disposal that can reduce the risk of pet exposure RECOGNIZE when to refer pet-owning patients to the pharmacist for counseling or poison control center guidance Release Date Release Date: January 15, 2026 Expiration Date: January 15, 2029 Course Fee Pharmacists $7 Pharmacy Technicians $4 There is no funding for this CE
Long-term safety considerations Clinical trials have demonstrated the promise of tirzepatide as a new medication for chronic weight management and T2DM
